Versari Annibale, Pipitone Nicolò, Casali Massimiliano, Jamar Francois, Pazzola Giulia
Unit of Nuclear Medicine, S. Maria Nuova Hospital-IRCCS of Reggio Emilia, Reggio Emilia, Italy -
Unit of Rheumatology, S. Maria Nuova Hospital-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Q J Nucl Med Mol Imaging. 2018 Mar;62(1):34-39. doi: 10.23736/S1824-4785.17.03044-8. Epub 2017 Nov 22.
Giant cell arteritis (GCA) and Takayasu's arteritis (TA) are large vessel vasculitis (LVV) primarily affecting the aorta and its major branches, mainly differentiated by the onset age (>50 years GCA and <40 years TA). In addition, temporal artery involvement and polymyalgia rheumatica are typical features of GCA, but not TA. Imaging techniques are required to secure the diagnosis of large-vessel vasculitides, and to monitor the disease course. Both morphological and metabolic imaging are involved. Morphological imaging is represented mainly by computerized tomography (CT), CT angiography, magnetic resonance (MR), MR angiography, color-Doppler sonography (CDS) and high-resolution CDS. Metabolic aspects of inflammatory process in LVV can be well studied by positron emission tomography/computed tomography with [18F]deoxyglucose ([18F]FDG PET/CT). It has an important increasing role in diagnosis, extent assessment and disease activity and therapy response evaluation. In the near future the concomitant development of increasingly powerful PET/CT scanners, of new radiopharmaceuticals more specific for inflammation, and of new PET/MRI hybrid scanners probably will lead to a further new step forward in the diagnosis and clinical management of LVV.
巨细胞动脉炎(GCA)和大动脉炎(TA)是主要累及主动脉及其主要分支的大血管血管炎(LVV),主要根据发病年龄进行区分(GCA发病年龄>50岁,TA发病年龄<40岁)。此外,颞动脉受累和风湿性多肌痛是GCA的典型特征,但TA并非如此。需要借助成像技术来确诊大血管血管炎,并监测疾病进程。这涉及形态学成像和代谢成像。形态学成像主要包括计算机断层扫描(CT)、CT血管造影、磁共振成像(MR)、MR血管造影、彩色多普勒超声(CDS)和高分辨率CDS。利用[18F]脱氧葡萄糖([18F]FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)可以很好地研究LVV炎症过程的代谢情况。它在诊断、范围评估以及疾病活动和治疗反应评估中发挥着越来越重要的作用。在不久的将来,功能日益强大的PET/CT扫描仪、对炎症更具特异性的新型放射性药物以及新型PET/MRI混合扫描仪的同步发展,可能会在LVV的诊断和临床管理方面带来进一步的新进展。